In an interview that took place at the European Society for Medical Oncology 2024 Congress in Barcelona, Spain, Timothy Yap, MBBS, PhD, medical oncologist, The University of Texas…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
What if it were possible to combine the technological capabilities of an entire laboratory on one single chip? Scientists all across Europe may be getting close. Scientists at…
NEW YORK (Reuters Health) – A novel VEGFR inhibitor, tivozanib, improves progression-free survival significantly in patients with metastatic renal cell carcinoma but does not improve overall survival, according…
NEW YORK (Reuters Health) – After primary surgery for early-stage endometrial cancer, adjuvant external beam radiation therapy confers no survival benefit overall, according to a Norwegian study. In…
NEW YORK (Reuters Health) – Among several different DNA-based quantitative polymerase chain reaction (qPCR) assays for detecting a critical JAK2 mutation in myeloproliferative neoplasms, one stands out as…
NEW YORK (Reuters Health) – There’s no evidence that starting treatment with the anti-obesity drug orlistat raises the likelihood of developing colorectal cancer, at least in the short…
By Anne Harding NEW YORK (Reuters Health) – Pediatric inflammatory bowel disease (IBD) patients are not at increased mortality risk compared with their IBD-free peers, but they do…
NEW YORK (Reuters Health) – The identification of differing patterns of oncogenic mutations in squamous cell carcinoma and adenocarcinoma of the cervix may lead to more targeted treatments,…
NEW YORK (Reuters Health) – The psychostimulant modafinil is no better than a placebo in improving fatigue, depression and cognitive function in patients with primary brain tumors (PBT),…
NEW YORK (Reuters Health) – The addition of bevacizumab to adjuvant chemotherapy does not improve invasive disease-free rates in women after resection of breast cancer that’s negative for…
By Will Boggs, MD NEW YORK (Reuters Health) – Patients with unresectable primary spinal sarcoma may benefit from carbon ion radiotherapy (CIRT), Japanese researchers say. Compared with proton…
